This article outlines the effects of neuromuscular blocking agents on neuromuscular junctions, indicating monitoring and recovery strategies.
Neuromuscular blocking agents (NMBAs), which act at neuromuscular junctions (NMJs), are used to induce neuromuscular blockade. Some of the terminology associated with NMBAs may be confused with that used in relation to locoregional anaesthesia (nerve blocks), although the two are distinct. This article outlines the NMJs and neurotransmission, commonly used NMBAs and their effects on the NMJs, methods for monitoring and antagonising NMB drugs, and factors that influence patient recovery.
No takes yet. Share an insight, caveat, or question.
Courtney Scales (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: